Morikawa, Yoshihiko http://orcid.org/0000-0002-1437-0374
Sakakibara, Hiroshi http://orcid.org/0000-0003-3904-7087
Miura, Masaru http://orcid.org/0000-0003-3314-0571
Funding for this research was provided by:
Tokyo Metropolitan Government
Japan Kawasaki Disease Research Center
Article History
Received: 19 May 2022
Accepted: 13 July 2022
First Online: 11 August 2022
Declarations
:
: The ethics committee at each institute approved this study. The study is registered in UMIN Clinical Trials Registry (No. UMIN000007174, registration date: January 31, 2012; ExternalRef removed).
: MM received honoraria from the Japan Blood Products Organization, Teijin Pharma Limited, Nihon Pharmaceutical, and Mitsubishi Tanabe Pharma Corporation which were unrelated to the submitted work. The other authors have no conflicts of interest to disclose.